Status:
COMPLETED
Intramuscular Injection of Human Chorionic Gonadotropin in Frozen Embryo Transfer Cycles
Lead Sponsor:
Royan Institute
Conditions:
Embryo Implantation
Eligibility:
FEMALE
20-40 years
Phase:
NA
Brief Summary
This study is a randomized controlled clinical trial to compare the pregnancy outcomes of infertile women with frozen embryo transfer. The study population in frozen embryo transfer cycles receive thr...
Detailed Description
During implantation, the biochemical crosstalk between the endometrium and embryo has a very important role. The endometrium secrets cytokines and growth factors that modulate embryonic differentiatio...
Eligibility Criteria
Inclusion
- Infertile women candidates for frozen embryo transfer
- Age 20-40 years
- Body Mass Index under than 30 Kg/m2
- Having at least three good quality embryos
Exclusion
- Women with hematologic and autoimmune disorders
- Couples with chromosomal and genetic abnormalities
- Women with uterine anomalies
- Women with uterine and ovaries surgical history
- Women with endometriosis and adenomyosis
- Women with hydrosalpinx
- Women with uterine fibroids
- Women with history of recurrent abortion or recurrent implantation failure
- Severe male factor infertility (azoospermia)
- Embryo donation cycle
- Endometrial thickness less than 8 millimeter on the day of embryo transfer
Key Trial Info
Start Date :
July 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 20 2023
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04855383
Start Date
July 1 2020
End Date
June 20 2023
Last Update
January 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royan Institute
Tehran, Iran, 16635-148